Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
KinoPharma Inc.
NCT06737406 · Common Warts
NCT06958237 · Common Warts, Plantar Warts
NCT05799157 · Verruca Vulgaris, Warts, and more
NCT06214559 · Warts, Plantar Wart, and more
NCT06749665 · Common Wart
Kawaharamachi Dermatology
Maebashi, Gunma
Tetsuya Dermatology
Himeji, Hyōgo
Takashima Dermatology
Kobe, Hyōgo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions